Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Melissa De Los Reyes"'
Autor:
Weimin Li, Ross Stewart, Thomas Powles, Joaquim Bellmunt, Feng Xiao, Ashok Gupta, Jill Walker, Melissa de los Reyes, Matthew Galsky, Sophie Wildsmith, Anne L’Hernault, Hannah Bye, Philip He, Qu Zhang, Rajiv Raja, Wendy Levin, Alexandra Drakaki, Michiel van der Heijden
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/bfecfa2ec4564ebcbea8a373a6c1ea02
Autor:
Carl Barrett, Maria Ascierto, Song Wu, Nathan Standifer, Melissa de los Reyes, Micheal Oberst, Rajv Raja
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/5c3d2d7a986d4daa8ddca0615a24657c
Autor:
Kellie Burnside, Annalisa Lembo, Melissa de Los Reyes, Anton Iliuk, Nguyen-Thao Binhtran, James E Connelly, Wan-Jung Lin, Byron Z Schmidt, Anthony R Richardson, Ferric C Fang, Weiguo Andy Tao, Lakshmi Rajagopal
Publikováno v:
PLoS ONE, Vol 5, Iss 6, p e11071 (2010)
Exotoxins, including the hemolysins known as the alpha (alpha) and beta (beta) toxins, play an important role in the pathogenesis of Staphylococcus aureus infections. A random transposon library was screened for S. aureus mutants exhibiting altered h
Externí odkaz:
https://doaj.org/article/91c528ffdf7247a8ade12714c06f1b8c
Autor:
Yihong Yao, Laura Richman, Chris Morehouse, Melissa de los Reyes, Brandon W. Higgs, Anmarie Boutrin, Barbara White, Anthony Coyle, James Krueger, Peter A. Kiener, Bahija Jallal
Publikováno v:
PLoS ONE, Vol 4, Iss 3 (2009)
Externí odkaz:
https://doaj.org/article/4a4d1a9b85d548c28cbfcd4104728447
Autor:
Yihong Yao, Laura Richman, Chris Morehouse, Melissa de los Reyes, Brandon W Higgs, Anmarie Boutrin, Barbara White, Anthony Coyle, James Krueger, Peter A Kiener, Bahija Jallal
Publikováno v:
PLoS ONE, Vol 3, Iss 7, p e2737 (2008)
BACKGROUND: Psoriasis is an immune-mediated disease characterized by aberrant epidermal differentiation, surface scale formation, and marked cutaneous inflammation. To better understand the pathogenesis of this disease and identify potential mediator
Externí odkaz:
https://doaj.org/article/6656647cca6841ab9c2874f8e6592ec6
Autor:
Sophie Wildsmith, Weimin Li, Song Wu, Ross Stewart, Nassim Morsli, Rajiv Raja, Qu Zhang, Jiabu Ye, Philip He, Jagdish Shetty, Alejandro Yovine, Nicholas Holoweckyj, Katia Real, Jill Walker, Magdalena Wrona, Melissa de los Reyes, Craig Barker, Jessica Whiteley, Robert Haddad, Lisa Licitra, Robert Ferris, Jérôme Fayette, Dan P. Zandberg, Lillian L. Siu, Ricard Mesía
Publikováno v:
Clinical Cancer Research. 29:2066-2074
Purpose: Biomarkers that predict response to immune checkpoint inhibitors (ICI) in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) are needed. This retrospective study assessed tumor mutational burden (TMB) and outcomes in t
Autor:
Sarah, Diver, Sriram, Sridhar, Latifa C, Khalfaoui, Richard J, Russell, Claire, Emson, Janet M, Griffiths, Melissa, de Los Reyes, Da, Yin, Gene, Colice, Christopher E, Brightling
Publikováno v:
Journal of Allergy and Clinical Immunology. 150:830-840
Understanding how asthma biomarkers relate to gene expression signatures could help identify drivers of pathogenesis.This post hoc exploratory analysis of the phase II tralokinumab trial MESOS (ClinicalTrials.gov identifier NCT02449473) aimed to prof
Autor:
James Ward, Mythri Ambatipudi, Terrance P O'Hanlon, Michael A. Smith, Melissa de Los Reyes, Adam Schiffenbauer, Saifur Rahman, Kamelia Zerrouki, Frederick W. Miller, Miguel A. Sanjuan, Jian‐Liang Li, Kerry A. Casey, Lisa G. Rider
Publikováno v:
Arthritis & Rheumatology.
Autor:
Ricard Mesía, Lillian L. Siu, Dan P. Zandberg, Jérôme Fayette, Robert Ferris, Lisa Licitra, Robert Haddad, Jessica Whiteley, Craig Barker, Melissa de los Reyes, Magdalena Wrona, Jill Walker, Katia Real, Nicholas Holoweckyj, Alejandro Yovine, Jagdish Shetty, Philip He, Jiabu Ye, Qu Zhang, Rajiv Raja, Nassim Morsli, Ross Stewart, Song Wu, Weimin Li, Sophie Wildsmith
FIG S2. Kaplan-Meier plot of OS in the durvalumab monotherapy, durvalumab plus tremelimumab and SoC treatment arms in the NLR ≤ 7 subgroup (A) and NLR > 7 subgroup (B) in EAGLE.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25a87e88a11e0049916dc65f88972d18
https://doi.org/10.1158/1078-0432.22551834.v1
https://doi.org/10.1158/1078-0432.22551834.v1
Autor:
Michael D. Oberst, Maria Libera Ascierto, Phillip A. Dennis, J. Carl Barrett, Melanie M. Frigault, Rajiv Raja, Shaad E. Abdullah, Ashok Gupta, Ronald Herbst, Ricardo J. Miragaia, Theresa A. Proia, Ina Bisha, Matthew Griffin, John Meekin, Philip Martin, Stephen Blackmore, Kathy Mulgrew, Raymond Rothstein, Rebecca Halpin, Yashaswi Shrestha, Melissa de los Reyes, Maria Jure-Kunkel, Nathan Standifer, Song Wu, Nabendu Pore
Marker genes for the monocyte-macrophage-DC subpopulations identified in Supplementary Figure 5H. Only genes with adjusted p-value < 0.01 and average log fold-change > 0.3 were included. gene, gene name; p_val, p-value calculated based on Wilcoxon te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::318ab2f876a4f6d65d1cc34e89e50b21
https://doi.org/10.1158/2159-8290.22540394
https://doi.org/10.1158/2159-8290.22540394